By I have spent six years working as a registered nurse in a small outpatient infusion clinic outside Portland, where I supervise hydration treatments and longer NAD+ drips. Most people arrive after hearing that NAD+ IV therapy may help with energy, mental clarity, recovery, or the effects of a demanding schedule. I take those hopes seriously, but I never present the infusion as a guaranteed fix. My job is to keep the session safe, explain what the patient may feel, and separate reasonable expectations from marketing promises.
The Work Begins Before the IV Is Placed
I learn more during the first 15 minutes than I do while hanging the infusion bag. I ask about medications, allergies, kidney concerns, heart conditions, recent illness, pregnancy, and any history of fainting during injections. I also check blood pressure, pulse, temperature, and the reason the person wants the treatment. A vague request for “more energy” often needs a longer conversation.
A patient last winter came in after several weeks of poor sleep and heavy travel. He expected one infusion to erase the effects of working late, skipping meals, and drinking too little water. I explained that an IV could not replace sleep or correct an untreated medical problem. He still chose to proceed after the clinical review, but his expectations were more grounded before I placed the catheter.
NAD+ is a coenzyme involved in normal cellular reactions, including processes related to energy metabolism. That biological role does not prove that an intravenous dose will create a noticeable benefit for every healthy person. I make that distinction clear because a compound can be essential inside the body without becoming a cure when delivered through an IV. The difference matters.
I also ask what the person has already tried. Someone with months of unexplained exhaustion may need a medical evaluation rather than a wellness infusion, especially if the fatigue comes with weight changes, chest discomfort, shortness of breath, or persistent dizziness. I will pause a session when the history raises concerns that belong in a primary care office or urgent setting. A drip should never delay proper diagnosis.
Why the Infusion Rate Changes the Experience
NAD+ sessions often take longer than basic hydration appointments because many patients tolerate the solution better at a slow rate. A standard saline bag may run comfortably in under an hour, while an NAD+ appointment can occupy two or more hours depending on the ordered dose and the patient’s response. I do not judge the session by how quickly the bag empties. The pace matters.
One resource I sometimes point people toward is NAD+ IV Therapy because its service page gives them a concrete sense of how a clinic may describe the treatment before they book. I still ask patients to discuss their health history directly with the treating provider rather than relying on a service page alone. A website can explain the appointment, but it cannot perform an individual medical screening. I want that boundary to remain clear.
Some people report warmth, nausea, pressure in the chest or abdomen, headache, or an uneasy feeling when the infusion runs too quickly. Those symptoms do not prove the treatment is working, and I never encourage a patient to endure significant discomfort for that reason. I slow the pump, reassess vital signs, and follow the clinic’s standing medical orders. If the symptoms do not settle, the infusion may need to stop.
A woman I treated last spring felt fine during the first 20 minutes, then developed a tight sensation in her stomach after the rate increased. Her blood pressure and pulse remained stable, but the discomfort was real. I reduced the rate and gave her time to settle before deciding whether to continue. She completed the session slowly, which added nearly an hour to the appointment.
I have seen patients arrive expecting an ordinary vitamin drip that they can finish during a lunch break. That expectation can create frustration when their body only tolerates a slower rate. I tell them to leave room in the schedule, bring something quiet to read, and avoid booking an important meeting immediately afterward. Rushing creates pressure that does not belong in an infusion chair.
What People Commonly Notice Afterward
The responses I hear vary widely. Some patients describe feeling alert later that day, while others notice nothing beyond the effects of resting and receiving fluid. A few say they sleep more deeply that night or feel less mentally foggy the following morning. Those reports are personal experiences, not proof of a predictable clinical result.
I remember a business owner who booked three appointments during a difficult work season. After the first session, he said he felt unusually focused for about 24 hours. The second appointment felt less dramatic, and after the third he was unsure whether anything had changed. His experience is a useful reminder that even one person may respond differently from session to session.
Hydration, food intake, sleep, caffeine use, stress, and the person’s starting condition can shape how the day feels after an infusion. A patient who arrives dehydrated may feel better partly because of the fluid rather than the NAD+ itself. Someone who spends three quiet hours away from a phone and a crowded office may also feel rested for reasons unrelated to the solution. I try not to assign every positive feeling to one ingredient.
I ask patients to watch for persistent pain, swelling, redness, drainage, or warmth near the IV site. Mild tenderness from the catheter can occur, but worsening symptoms deserve attention. I also tell them to seek medical help for breathing difficulty, severe chest pain, fainting, facial swelling, or other serious reactions. That part is simple.
The Claims I Treat With Caution
NAD+ IV therapy is often discussed in connection with aging, athletic performance, brain function, addiction recovery, and chronic fatigue. The scientific interest is real, but the strength of evidence differs sharply from one claim to another. Research into NAD+ biology does not automatically validate every commercial use of intravenous NAD+. I avoid turning early findings or laboratory work into promises about human outcomes.
Dose also varies between clinics. One practice may offer a few hundred milligrams during an introductory session, while another may advertise a much larger protocol spread across several days. Different formulas, infusion rates, patient groups, and outcome measures make casual comparisons difficult. I become cautious whenever someone claims that one dose works for everyone.
I have met patients who were told that uncomfortable sensations meant their cells were “recharging.” I do not use that explanation because it can pressure people to ignore symptoms that should be assessed. Discomfort may be related to the infusion rate, individual sensitivity, anxiety, vein irritation, or another cause. A dramatic feeling is not a reliable measure of benefit.
I am equally careful with claims about reversing aging. NAD+ levels and cellular metabolism are active areas of research, yet a wellness infusion cannot be assumed to reverse the complex biological processes involved in aging. People deserve language that reflects uncertainty rather than sales language dressed as medicine. I would rather lose a booking than create false confidence.
How I Judge Whether Continuing Makes Sense
I encourage patients to define one practical goal before beginning a series. They might track afternoon concentration, recovery after training, sleep quality, or the number of days they feel unusually fatigued. I prefer a simple record covering 24 to 48 hours after each session. Without a clear goal, almost any normal change can be interpreted as success.
Cost matters too. A series of infusions can total several thousand dollars, depending on the clinic, dose, and number of visits. I ask patients to consider whether the benefit they notice is meaningful enough to justify that expense. Feeling slightly refreshed for one evening may not carry the same value as a consistent improvement that affects daily work or recovery.
I also look at tolerance. A person who experiences strong nausea during every appointment and needs four hours to complete a small dose may decide the process is not worthwhile. Another patient may sit comfortably, read for two hours, and report a useful improvement afterward. Neither decision is wrong when it is based on honest observation and proper clinical guidance.
More treatment is not always better. If several sessions produce no clear change, I do not believe the answer is automatically a larger dose or a longer package. It may be time to stop, reassess the original goal, or speak with a physician about other causes of the symptoms. Continuing out of habit can become expensive and distracting.
The Details That Make a Clinic Feel Responsible
I pay attention to who reviews the medical history, who writes the order, and who remains available if a reaction occurs. A responsible clinic should be able to explain its screening process in plain language. Staff should know the dose, ingredients, expected appointment length, and steps used when a patient becomes unwell. Evasive answers make me uncomfortable.
Clean technique is basic, but I still watch it closely. I use a new sterile catheter, clean the skin properly, label the infusion, confirm the order, and document the patient’s response. During a two-hour appointment, I reassess the IV site several times rather than assuming it will remain fine. Small details prevent avoidable problems.
I am also wary of clinics that sell large prepaid packages before a patient has completed one session. Tolerance and response cannot be predicted from a phone call. I prefer beginning with a medically appropriate introductory visit, then reviewing the experience before another appointment is scheduled. That approach gives the patient room to make a calm decision.
Clear boundaries are part of good care. NAD+ IV therapy should not be presented as a replacement for prescribed treatment, mental health care, sleep, nutrition, or investigation of persistent symptoms. I can supervise an infusion, but I cannot promise that it will solve a problem with an unknown cause. Honest limits protect the patient more than polished claims do.
After years beside infusion chairs, I remain interested in NAD+ therapy without treating it as settled medicine. I have seen people report useful changes, people feel no difference, and people decide the discomfort or cost was not justified. I consider a session successful when the patient was screened carefully, treated safely, and given enough honest information to judge the result. That standard matters more to me than selling the next drip.
